Why the study?
The study aimed to define the association between altitude and ticagrelor-associated dyspnea in patients with acute coronary syndrome.
Does high altitude increase the incidence of ticagrelor-induced dyspnea in patients with acute coronary syndrome compared to low altitude?
Does high altitude increase the incidence of ticagrelor-induced dyspnea in patients with acute coronary syndrome compared to low altitude?
High altitude is associated with a higher incidence of ticagrelor-induced dyspnea in patients with acute coronary syndrome.
Answers are grounded in this paper and cite their sources.
May heighten ticagrelor dyspnea at higher altitudes in ACS; leaves open whether prospective trials should test altitude-specific strategies.
OBJECTIVE: This study aimed to define the association between altitude and ticagrelor-associated dyspnea in patients with acute coronary syndrome (ACS). METHODS: We studied consecutive patients with de novo ACS who were admitted to two centers at a low altitude (18 and 25 m, n = 65) and two centers at a high altitude (1313 and 1041 m, n = 136). We managed them with ticagrelor between May 2017 and September 2017. Patients with ACS underwent an interventional procedure within <90 minutes in those with ST elevation and within <3 hours in those without ST elevation. We recorded the incidence of dyspnea in patients with ACS receiving ticagrelor therapy. RESULTS: The mean age was 59.5 ± 10 years, and the mean ejection fraction was 43% ± 18%. A total of 110 (56.7%) patients had ST elevation and 84 (43.3%) did not. There were no significant differences in cardiac risk factors, concurrent medications, or procedural variables between the two groups. Dyspnea developed during hospitalization in 53 (38%) patients from high-altitude centers and in 13 (20%) patients from low-altitude centers (66 patients represented 32% of the total ACS cohort). CONCLUSIONS: Dyspnea is a common multifactorial symptom in patients following development of ACS. Ticagrelor-induced dyspnea appears to be associated with altitude.
No takes yet. Share an insight, caveat, or question.
Kocabay et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: